Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Air Stacking-Assisted Diaphragmatic Breathing in Stroke

5 de mayo de 2026 actualizado por: jang ji-hun

Effects of Diaphragmatic Breathing Exercise Using the Air Stacking Technique on Respiratory and Trunk Function in Patients With Stroke: A Randomized Controlled Trial

The purpose of this study is to investigate whether a diaphragmatic breathing exercise using the air stacking technique can improve respiratory function and trunk control in patients with stroke. The experimental group will perform an air stacking-based diaphragmatic breathing exercise using an Ambu-bag, combined with neurodevelopmental treatment, three times per week for 20 minutes over a 4-week period. The control group will receive therapist-guided diaphragmatic breathing exercises with the same frequency and duration, together with the same neurodevelopmental treatment. All participants will be assessed before and after the intervention for pulmonary function, chest wall expansion, and trunk control ability, as well as the Korean version of the Trunk Impairment Scale (K-TIS), the Five Times Sit-to-Stand Test (FTSTS), and the Borg Rating of Perceived Exertion (Borg RPE). Changes between the two groups will be compared to determine the therapeutic effectiveness of the air stacking technique.

Descripción general del estudio

Descripción detallada

This clinical trial is a randomized controlled study designed to evaluate the effects of a diaphragmatic breathing exercise using the air stacking technique on respiratory and trunk function in patients with stroke. Patients with stroke are prone to respiratory muscle weakness, reduced chest wall expansion, and impaired trunk control, which can limit functional recovery and increase the risk of pulmonary complications. The air stacking technique increases lung volume and chest expansion through consecutive inspirations without exhalation and is known to facilitate more effective breathing and coughing, but its therapeutic effects in patients with stroke have not yet been fully established.

In this study, 20 patients with stroke will be randomly assigned to an experimental group (n = 10) or a control group (n = 10), using blocked randomization to ensure balance between groups. To enhance the objectivity of outcome assessment, all evaluations will be performed by an assessor who is blinded to group allocation. The experimental group will perform an air stacking-based diaphragmatic breathing exercise using an Ambu-bag, three times per week for 20 minutes over a 4-week period, in addition to neurodevelopmental treatment. The control group will receive therapist-guided diaphragmatic breathing exercises with the same frequency and duration, combined with the same neurodevelopmental treatment program. Both groups will receive the interventions for 4 weeks in the same rehabilitation setting.

All participants will undergo assessments before the start of the intervention and after completion of the 4-week program. Outcome measures will include pulmonary function tests (for example, FVC and FEV1), chest wall expansion, and trunk control ability. In addition, trunk function and functional mobility will be evaluated using the Korean version of the Trunk Impairment Scale (K-TIS) and the Five Times Sit-to-Stand Test (FTSTS), and perceived exertion during exercise will be assessed using the Borg Rating of Perceived Exertion (Borg RPE). Pre- to post-intervention changes will be calculated for each participant, and differences in these changes between the experimental and control groups will be analyzed.

The aim of this study is to determine whether a diaphragmatic breathing exercise using the air stacking technique provides additional benefits over conventional diaphragmatic breathing in improving pulmonary function, chest wall expansion, trunk control, and functional performance in patients with stroke. The findings are expected to demonstrate the therapeutic potential and clinical feasibility of an Ambu-bag-assisted air stacking technique and to contribute to the development of more effective respiratory and trunk rehabilitation strategies for individuals with stroke.

Tipo de estudio

Intervencionista

Inscripción (Actual)

20

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Daegu
      • Daegu, Daegu, Corea del Sur, 41199
        • Daegu Fatima Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Inpatients diagnosed with stroke (intracerebral hemorrhage or cerebral infarction) at a general hospital in Daegu, currently receiving physical therapy
  • Onset of stroke at least 3 months prior to enrollment
  • Spasticity grade of 2 or less on the Modified Ashworth Scale
  • No congenital deformity or fracture of the thorax or other orthopedic conditions affecting the chest wall
  • No history of pulmonary disease before or after the stroke
  • Able to perform respiratory exercises as instructed
  • Mini-Mental State Examination-Korean version (MMSE-K) score of 24 or higher, indicating sufficient cognitive ability to understand the study procedures
  • Presence of decreased pulmonary function (reduced pulmonary function test parameters) at baseline

Exclusion Criteria:

  • Acute stroke status or onset of stroke less than 3 months prior to enrollment
  • Severe cardiovascular or respiratory disease that makes participation in respiratory exercise unsafe or impossible
  • Cognitive impairment or communication disorder that prevents understanding or performing the study procedures
  • Any other medical or safety condition judged by the investigator to make participation in the study inappropriate

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Air stacking-assisted diaphragmatic breathing
articipants in this arm will receive diaphragmatic breathing exercises using the air stacking technique with an Ambu-bag three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
Diaphragmatic breathing exercise using the air stacking technique with an Ambu-bag, performed three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
Comparador activo: diaphragmatic breathing
Participants in this arm will receive diaphragmatic breathing exercises three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.
diaphragmatic breathing exercise performed three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Forced Vital Capacity (FVC)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Forced vital capacity (FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FVC from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Forced Expiratory Volume in 1 Second (FEV1)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Forced expiratory volume in 1 second (FEV1) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1 from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in FEV1/FVC ratio
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
The ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in FEV1/FVC from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Peak Expiratory Flow (PEF)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Peak expiratory flow (PEF) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention. The outcome measure is the change in PEF from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Trunk Function (Korean Version of the Trunk Impairment Scale, K-TIS)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Trunk function will be assessed using the Korean version of the Trunk Impairment Scale (K-TIS) at baseline and 4 weeks after the start of the intervention. The K-TIS is a clinical scale ranging from 0 to 23, with higher scores indicating better trunk function. The outcome measure is the change in K-TIS total score from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Functional Lower Extremity Performance (Five Times Sit-to-Stand Test, FTSTS)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Functional lower extremity performance will be assessed using the Five Times Sit-to-Stand Test (FTSTS) at baseline and 4 weeks after the start of the intervention. The FTSTS records the time in seconds required to complete five repetitions of rising from and returning to a seated position. Higher times indicate poorer functional performance. The outcome measure is the change in FTSTS completion time from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention
Change in Perceived Exertion (Borg Rating of Perceived Exertion Scale)
Periodo de tiempo: Baseline and 4 weeks after the start of intervention
Perceived exertion during breathing exercises will be assessed using the Borg Rating of Perceived Exertion Scale at baseline and 4 weeks after the start of the intervention. The Borg scale ranges from 6 to 20, with higher scores indicating greater perceived exertion. The outcome measure is the change in Borg scale score from baseline to 4 weeks in each group.
Baseline and 4 weeks after the start of intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

25 de septiembre de 2025

Finalización primaria (Actual)

21 de febrero de 2026

Finalización del estudio (Actual)

21 de febrero de 2026

Fechas de registro del estudio

Enviado por primera vez

28 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

5 de mayo de 2026

Publicado por primera vez (Actual)

11 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir